Catalog #DRA197
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| DRA197 | 50ug | $170.00 | ||
| DRA197 | 500ug | $1,280.00 | ||
| DRA197 | 1mg | $1,920.00 |
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by our E.coli expression system and the target gene encoding Met1-Ala419 (P13L, E31del, R32del, S33del, R203K, G204R) is expressed with a 6His tag at the N-terminus. The mutations were identified in the SARS-CoV-2 variant (known as Omicron/B.1.1.529 lineage) which emerged in South Africa.
| Application fields | In Vitro Diagnostics |
|---|---|
| Protein Tag | C-6His |
| Species | SARS-CoV-2 |
| Alias | SARS-CoV-2 coronavirus NP Protein; SARS-CoV-2 np Protein; SARS-CoV-2 novel coronavirus Nucleoprotein Protein |
| Accession No | P0DTC9 |
| Formulation | Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 300mM NaCI, 1mM EDTA, pH8.0 |
| Purity | > 95% by SDS-PAGE under reducing conditions |
| Expression System | E. coli |